- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Varian sells 4-T MR system for brain study
Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and
Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and psychiatric disorders.
Very high field (4-tesla) systems such as this one cost from $3 million to $4 million and are used only in research applications. In addition to its imaging capabilities, the Varian system can be used for in vivo nuclear MR spectroscopy, a technique for determining structural and functional relationships of chemical compounds in the brain.
Systems have also been ordered by the University of California, Berkeley; Emory University in Atlanta; and the National Institute for Environmental Studies in Tsukuba, Japan.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
